Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

NCT00346827 is registered in ClinicalTrials.gov with Britannia Pharmaceuticals Ltd. as lead sponsor.

NCT NCT00346827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00346827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
Lead sponsor
Britannia Pharmaceuticals Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2006
Completion date
August 31, 2007
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease